{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T06:36:45Z","timestamp":1794724605440,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Research and Development Plan of China","award":["2016YFC1200500"],"award-info":[{"award-number":["2016YFC1200500"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572014"],"award-info":[{"award-number":["81572014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81802036"],"award-info":[{"award-number":["81802036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Potent granulomatous inflammation responses induced by schistosome eggs and resultant fibrosis are the primary causes of morbidity in schistosomiasis. Recombinant Sj16 (rSj16), a 16-kDa protein of<jats:italic>Schistosoma japonicum<\/jats:italic>produced in<jats:italic>Escherichia coli<\/jats:italic>, has been demonstrated to have novel immunoregulatory effects<jats:italic>in vivo<\/jats:italic>and<jats:italic>in vitro<\/jats:italic>. Thus, this study investigated the anti-inflammatory and anti-fibrotic effects of rSj16 treatment in<jats:italic>S. japonicum-<\/jats:italic>infected mice and demonstrated the immune modulation between the schistosome and the host.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p><jats:italic>Schistosoma japonicum<\/jats:italic>infected mice were treated with the rSj16 protein and Sj16 peptide at different time points post-infection to assess their efficacy at the optimal time point. Sj16 peptide and\/or Praziquantel (PZQ) treatments were initiated at week 5 post-infection to compare the therapeutic efficacy of each regimen. Hepatic granulomatous inflammation, fibrosis and cytokine production (pro-inflammatory, Th1, Th2, Th17 and regulatory cytokines IL-10) were detected. Moreover, M2 macrophages were measured to illuminate the mechanisms of Sj16.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The rSj16 protein and Sj16 peptide had significant protective effects in<jats:italic>S. japonicum<\/jats:italic>-infected mice, as shown by decreased granuloma formation, areas of collagen deposition and inhibition of pro-inflammatory Th1, Th2 and Th17 cytokine production. These protective activities were more obvious when animals were treated with either the Sj16 protein or peptide at early stages post-infection. Interestingly, the combined treatment of PZQ and Sj16 was more effective and upregulated IL-10 production than administration of PZQ alone in infected mice. Furthermore, the Sj16 treatment alleviated the pathological effects associated with activated M2 macrophages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>This study demonstrates the anti-inflammatory and anti-fibrotic effects of rSj16 in schistosomiasis. Therefore, the combination of rSj16 with PZQ could be a viable and promising therapeutic strategy for schistosomiasis. In addition, this investigation provides additional information on schistosome-mediated immune modulation and host-parasite interactions.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13071-019-3697-z","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T11:03:03Z","timestamp":1569236583000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Recombinant Sj16 protein with novel activity alleviates hepatic granulomatous inflammation and fibrosis induced by Schistosoma japonicum associated with M2 macrophages in a mouse model"],"prefix":"10.1186","volume":"12","author":[{"given":"Jia","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongdao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"3697_CR1","unstructured":"WHO. Schistosomiasis. http:\/\/www.who.int\/news-room\/fact-sheets\/detail\/schistosomiasis . Accessed 23 May 2019."},{"key":"3697_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/S1473-3099(06)70521-7","volume":"6","author":"P Steinmann","year":"2006","unstructured":"Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis. 2006;6:411\u201325.","journal-title":"Lancet Infect Dis"},{"key":"3697_CR3","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.actatropica.2013.12.001","volume":"141","author":"CH King","year":"2015","unstructured":"King CH. Health metrics for helminth infections. Acta Trop. 2015;141:150\u201360.","journal-title":"Acta Trop"},{"key":"3697_CR4","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1111\/j.0105-2896.2004.00176.x","volume":"201","author":"TA Wynn","year":"2004","unstructured":"Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM. Immunopathogenesis of schistosomiasis. Immunol Rev. 2004;201:156\u201367.","journal-title":"Immunol Rev."},{"key":"3697_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1097\/00001432-200410000-00009","volume":"17","author":"BJ Vennervald","year":"2004","unstructured":"Vennervald BJ, Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis. 2004;17:439\u201347.","journal-title":"Curr Opin Infect Dis"},{"key":"3697_CR6","doi-asserted-by":"publisher","first-page":"d2651","DOI":"10.1136\/bmj.d2651","volume":"342","author":"DJ Gray","year":"2011","unstructured":"Gray DJ, Ross AG, Li YS, McManus DP. Diagnosis and management of schistosomiasis. BMJ. 2011;342:d2651.","journal-title":"BMJ."},{"key":"3697_CR7","first-page":"149","volume":"72","author":"F Von Lichtenberg","year":"1973","unstructured":"Von Lichtenberg F, Erickson DG, Sadun EH. Comparative histopathology of schistosome granulomas in the hamster. Am J Pathol. 1973;72:149\u201378.","journal-title":"Am J Pathol."},{"key":"3697_CR8","first-page":"279","volume":"80","author":"KS Warren","year":"1975","unstructured":"Warren KS, Boros DL, Hang LM, Mahmoud AA. The Schistosoma japonicum egg granuloma. Am J Pathol. 1975;80:279\u201394.","journal-title":"Am J Pathol."},{"key":"3697_CR9","doi-asserted-by":"publisher","first-page":"775","DOI":"10.4269\/ajtmh.1998.59.775","volume":"59","author":"CF Hatz","year":"1998","unstructured":"Hatz CF, Vennervald BJ, Nkulila T, Vounatsou P, Kombe Y, Mayombana C, et al. Evolution of Schistosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania. Am J Trop Med Hyg. 1998;59:775\u201381.","journal-title":"Am J Trop Med Hyg."},{"key":"3697_CR10","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4172\/2329-9088.1000135","volume":"1","author":"DU Olveda","year":"2013","unstructured":"Olveda DU, Li Y, Olveda RM, Lam AK, Chau TN, Harn DA, et al. Bilharzia: pathology, diagnosis, management and control. Trop Med Surg. 2013;1:135.","journal-title":"Trop Med Surg."},{"key":"3697_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nri1601","volume":"5","author":"DW Dunne","year":"2005","unstructured":"Dunne DW, Cooke A. A worm\u02bcs eye view of the immune system: consequences for evolution of human autoimmune disease. Nat Rev Immunol. 2005;5:420\u20136.","journal-title":"Nat Rev Immunol."},{"key":"3697_CR12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3389\/fimmu.2013.00039","volume":"4","author":"SK Lundy","year":"2013","unstructured":"Lundy SK, Lukacs NW. Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Front Immunol. 2013;4:39.","journal-title":"Front Immunol."},{"key":"3697_CR13","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.4049\/jimmunol.175.6.3920","volume":"175","author":"LI Rutitzky","year":"2005","unstructured":"Rutitzky LI, Lopes da Rosa JR, Stadecker MJ. Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J Immunol. 2005;175:3920\u20136.","journal-title":"J Immunol."},{"key":"3697_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nri843","volume":"2","author":"EJ Pearce","year":"2002","unstructured":"Pearce EJ, MacDonald AS. The immunobiology of schistosomiasis. Nat Rev Immunol. 2002;2:499\u2013511.","journal-title":"Nat Rev Immunol."},{"key":"3697_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Investig. 2012;122:787\u201395.","journal-title":"J Clin Investig"},{"key":"3697_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958\u201369.","journal-title":"Nat Rev Immunol."},{"key":"3697_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23\u201335.","journal-title":"Nat Rev Immunol"},{"key":"3697_CR18","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nri1412","volume":"4","author":"TA Wynn","year":"2004","unstructured":"Wynn TA. Fibrotic disease and the T(H)1\/T(H)2 paradigm. Nat Rev Immunol. 2004;4:583\u201394.","journal-title":"Nat Rev Immunol."},{"key":"3697_CR19","doi-asserted-by":"publisher","first-page":"e1002003","DOI":"10.1371\/journal.ppat.1002003","volume":"7","author":"JE Allen","year":"2011","unstructured":"Allen JE, Wynn TA. Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog. 2011;7:e1002003.","journal-title":"PLoS Pathog."},{"key":"3697_CR20","doi-asserted-by":"publisher","first-page":"6438","DOI":"10.4049\/jimmunol.0902009","volume":"184","author":"DR Herbert","year":"2010","unstructured":"Herbert DR, Orekov T, Roloson A, Ilies M, Perkins C, O\u2019Brien W, et al. Arginase I suppresses IL-12\/IL-23p40-driven intestinal inflammation during acute schistosomiasis. J Immunol. 2010;184:6438\u201346.","journal-title":"J Immunol."},{"key":"3697_CR21","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/S1074-7613(04)00107-4","volume":"20","author":"DR Herbert","year":"2004","unstructured":"Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, et al. Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity. 2004;20:623\u201335.","journal-title":"Immunity."},{"key":"3697_CR22","doi-asserted-by":"publisher","first-page":"29844","DOI":"10.1038\/srep29844","volume":"6","author":"H Peng","year":"2016","unstructured":"Peng H, Zhang Q, Li X, Liu Z, Shen J, Sun R, et al. IL-33 contributes to Schistosoma japonicum-induced hepatic pathology through induction of M2 macrophages. Sci Rep. 2016;6:29844.","journal-title":"Sci Rep."},{"key":"3697_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.pt.2004.01.004","volume":"20","author":"W Noel","year":"2004","unstructured":"Noel W, Raes G, Hassanzadeh Ghassabeh G, De Baetselier P, Beschin A. Alternatively activated macrophages during parasite infections. Trends Parasitol. 2004;20:126\u201333.","journal-title":"Trends Parasitol."},{"key":"3697_CR24","doi-asserted-by":"publisher","first-page":"e1000371","DOI":"10.1371\/journal.ppat.1000371","volume":"5","author":"JT Pesce","year":"2009","unstructured":"Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, Smith AM, et al. Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog. 2009;5:e1000371.","journal-title":"PLoS Pathog."},{"key":"3697_CR25","doi-asserted-by":"publisher","first-page":"e1004372","DOI":"10.1371\/journal.ppat.1004372","volume":"10","author":"KM Vannella","year":"2014","unstructured":"Vannella KM, Barron L, Borthwick LA, Kindrachuk KN, Narasimhan PB, Hart KM, et al. Incomplete deletion of IL-4Ralpha by LysM(Cre) reveals distinct subsets of M2 macrophages controlling inflammation and fibrosis in chronic schistosomiasis. PLoS Pathog. 2014;10:e1004372.","journal-title":"PLoS Pathog."},{"key":"3697_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.pt.2003.09.005","volume":"19","author":"A Fenwick","year":"2003","unstructured":"Fenwick A, Savioli L, Engels D, Robert Bergquist N, Todd MH. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 2003;19:509\u201315.","journal-title":"Trends Parasitol."},{"key":"3697_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-018-0013-8","volume":"4","author":"DP McManus","year":"2018","unstructured":"McManus DP, Dunne DW, Sacko M, Utzinger J, Vennervald BJ, Zhou XN. Schistosomiasis. Nat Rev Dis Primers. 2018;4:13.","journal-title":"Nat Rev Dis Primers."},{"key":"3697_CR28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4269\/ajtmh.1991.45.360","volume":"45","author":"MA Homeida","year":"1991","unstructured":"Homeida MA, el Tom I, Nash T, Bennett JL. Association of the therapeutic activity of praziquantel with the reversal of Symmers\u02bc fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg. 1991;45:360\u20135.","journal-title":"Am J Trop Med Hyg."},{"issue":"Suppl. 1","key":"3697_CR29","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s00436-002-0751-z","volume":"90","author":"D Cioli","year":"2003","unstructured":"Cioli D, Pica-Mattoccia L. Praziquantel. Parasitol Res. 2003;90(Suppl. 1):S3\u20139.","journal-title":"Parasitol Res."},{"key":"3697_CR30","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-3024.2012.01377.x","volume":"34","author":"XJ Sun","year":"2012","unstructured":"Sun XJ, Li R, Sun X, Zhou Y, Wang Y, Liu XJ, et al. Unique roles of Schistosoma japonicum protein Sj16 to induce IFN-gamma and IL-10 producing CD4(+)CD25(+) regulatory T cells in vitro and in vivo. Parasite Immunol. 2012;34:430\u20139.","journal-title":"Parasite Immunol."},{"key":"3697_CR31","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1007\/s00436-011-2782-9","volume":"110","author":"X Sun","year":"2012","unstructured":"Sun X, Lv Z, Peng H, Fung M, Yang L, Yang J, et al. Effects of a recombinant schistosomal-derived anti-inflammatory molecular (rSj16) on the lipopolysaccharide (LPS)-induced activated RAW264.7. Parasitol Res. 2012;110:2429\u201337.","journal-title":"Parasitol Res."},{"key":"3697_CR32","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/j.1365-3024.2010.01240.x","volume":"32","author":"X Sun","year":"2010","unstructured":"Sun X, Liu YH, Lv ZY, Yang LL, Hu SM, Zheng HQ, et al. rSj16, a recombinant protein of Schistosoma japonicum-derived molecule, reduces severity of the complete Freund\u02bcs adjuvant-induced adjuvant arthritis in rats\u2019 model. Parasite Immunol. 2010;32:739\u201348.","journal-title":"Parasite Immunol."},{"key":"3697_CR33","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.7150\/thno.20359","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L, Xie H, Xu L, Liao Q, Wan S, Yu Z, et al. rSj16 protects against DSS-induced colitis by inhibiting the PPAR-alpha signaling pathway. Theranostics. 2017;7:3446\u201360.","journal-title":"Theranostics."},{"key":"3697_CR34","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijpara.2008.06.017","volume":"39","author":"S Hu","year":"2009","unstructured":"Hu S, Wu Z, Yang L, Fung MC. Molecular cloning and expression of a functional anti-inflammatory protein, Sj16, of Schistosoma japonicum. Int J Parasitol. 2009;39:191\u2013200.","journal-title":"Int J Parasitol."},{"key":"3697_CR35","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1645\/GE-2692.1","volume":"98","author":"S Hu","year":"2012","unstructured":"Hu S, Yang L, Wu Z, Wong CS, Fung MC. Suppression of adaptive immunity to heterologous antigens by SJ16 of Schistosoma japonicum. J Parasitol. 2012;98:274\u201383.","journal-title":"J Parasitol."},{"key":"3697_CR36","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.exppara.2018.01.013","volume":"185","author":"MMK Sobhy","year":"2018","unstructured":"Sobhy MMK, Mahmoud SS, El-Sayed SH, Rizk EMA, Raafat A, Negm MSI. Impact of treatment with a protein tyrosine kinase inhibitor (Genistein) on acute and chronic experimental Schistosoma mansoni infection. Exp Parasitol. 2018;185:115\u201323.","journal-title":"Exp Parasitol."},{"key":"3697_CR37","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1590\/S0074-02762002000300019","volume":"97","author":"PI Bonesso-Sabadini","year":"2002","unstructured":"Bonesso-Sabadini PI, de Souza Dias LC. Altered response of strain of Schistosoma mansoni to oxamniquine and praziquantel. Mem Inst Oswaldo Cruz. 2002;97:381\u20135.","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"3697_CR38","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1007\/s00436-014-3973-y","volume":"113","author":"J Shen","year":"2014","unstructured":"Shen J, Xu L, Liu Z, Li N, Wang L, Lv Z, et al. Gene expression profile of LPS-stimulated dendritic cells induced by a recombinant Sj16 (rSj16) derived from Schistosoma japonicum. Parasitol Res. 2014;113:3073\u201383.","journal-title":"Parasitol Res."},{"key":"3697_CR39","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1007\/s00436-016-5247-3","volume":"115","author":"X Sun","year":"2016","unstructured":"Sun X, Yang F, Shen J, Liu Z, Liang J, Zheng H, et al. Recombinant Sj16 from Schistosoma japonicum contains a functional N-terminal nuclear localization signal necessary for nuclear translocation in dendritic cells and interleukin-10 production. Parasitol Res. 2016;115:4559\u201371.","journal-title":"Parasitol Res."},{"key":"3697_CR40","doi-asserted-by":"publisher","first-page":"3317","DOI":"10.4049\/jimmunol.0901504","volume":"183","author":"PM Smith","year":"2009","unstructured":"Smith PM, Shainheit MG, Bazzone LE, Rutitzky LI, Poltorak A, Stadecker MJ. Genetic control of severe egg-induced immunopathology and IL-17 production in murine schistosomiasis. J Immunol. 2009;183:3317\u201323.","journal-title":"J Immunol."},{"key":"3697_CR41","doi-asserted-by":"publisher","first-page":"10214","DOI":"10.1073\/pnas.1708578114","volume":"114","author":"J Shen","year":"2017","unstructured":"Shen J, Lai DH, Wilson RA, Chen YF, Wang LF, Yu ZL, et al. Nitric oxide blocks the development of the human parasite Schistosoma japonicum. Proc Natl Acad Sci USA. 2017;114:10214\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3697_CR42","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1002\/eji.201141670","volume":"41","author":"FO Martinez","year":"2011","unstructured":"Martinez FO. Regulators of macrophage activation. Eur J Immunol. 2011;41:1531\u20134.","journal-title":"Eur J Immunol."},{"key":"3697_CR43","doi-asserted-by":"publisher","first-page":"752","DOI":"10.4269\/ajtmh.1992.46.752","volume":"46","author":"AW Cheever","year":"1992","unstructured":"Cheever AW, Macedonia JG, Deb S, Cheever EA, Mosimann JE. Persistence of eggs and hepatic fibrosis after treatment of Schistosoma mansoni-infected mice. Am J Trop Med Hyg. 1992;46:752\u20138.","journal-title":"Am J Trop Med Hyg."},{"key":"3697_CR44","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0898-6568(02)00075-X","volume":"15","author":"JJ Haddad","year":"2003","unstructured":"Haddad JJ, Saade NE, Safieh-Garabedian B. Interleukin-10 and the regulation of mitogen-activated protein kinases: are these signalling modules targets for the anti-inflammatory action of this cytokine? Cell Signal. 2003;15:255\u201367.","journal-title":"Cell Signal."},{"key":"3697_CR45","doi-asserted-by":"publisher","first-page":"16513","DOI":"10.1074\/jbc.274.23.16513","volume":"274","author":"JK Riley","year":"1999","unstructured":"Riley JK, Takeda K, Akira S, Schreiber RD. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem. 1999;274:16513\u201321.","journal-title":"J Biol Chem."},{"key":"3697_CR46","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.4049\/jimmunol.138.10.3448","volume":"138","author":"JM Balloul","year":"1987","unstructured":"Balloul JM, Grzych JM, Pierce RJ, Capron A. A purified 28,000 dalton protein from Schistosoma mansoni adult worms protects rats and mice against experimental schistosomiasis. J Immunol. 1987;138:3448\u201353.","journal-title":"J Immunol."},{"key":"3697_CR47","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1365-3024.1991.tb00545.x","volume":"13","author":"D Boulanger","year":"1991","unstructured":"Boulanger D, Reid GD, Sturrock RF, Wolowczuk I, Balloul JM, Grezel D, et al. Immunization of mice and baboons with the recombinant Sm28GST affects both worm viability and fecundity after experimental infection with Schistosoma mansoni. Parasite Immunol. 1991;13:473\u201390.","journal-title":"Parasite Immunol."},{"key":"3697_CR48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.163.2.1045","volume":"163","author":"JB Sun","year":"1999","unstructured":"Sun JB, Mielcarek N, Lakew M, Grzych JM, Capron A, Holmgren J, et al. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice. J Immunol. 1999;163:1045\u201352.","journal-title":"J Immunol."},{"key":"3697_CR49","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/ki.1997.187","volume":"51","author":"SM Wahl","year":"1997","unstructured":"Wahl SM, Frazier-Jessen M, Jin WW, Kopp JB, Sher A, Cheever AW. Cytokine regulation of schistosome-induced granuloma and fibrosis. Kidney Int. 1997;51:1370\u20135.","journal-title":"Kidney Int."},{"key":"3697_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.cyto.2009.07.581","volume":"48","author":"H Tallima","year":"2009","unstructured":"Tallima H, Salah M, Guirguis FR, El Ridi R. Transforming growth factor-beta and Th17 responses in resistance to primary murine schistosomiasis mansoni. Cytokine. 2009;48:239\u201345.","journal-title":"Cytokine."},{"key":"3697_CR51","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1055\/s-0030-1255354","volume":"30","author":"TA Wynn","year":"2010","unstructured":"Wynn TA, Barron L. Macrophages: master regulators of inflammation and fibrosis. Semin Liver Dis. 2010;30:245\u201357.","journal-title":"Semin Liver Dis."},{"key":"3697_CR52","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1002\/eji.201141869","volume":"41","author":"L Barron","year":"2011","unstructured":"Barron L, Wynn TA. Macrophage activation governs schistosomiasis-induced inflammation and fibrosis. Eur J Immunol. 2011;41:2509\u201314.","journal-title":"Eur J Immunol."},{"key":"3697_CR53","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-3024.2005.00789.x","volume":"27","author":"SJ Jenkins","year":"2005","unstructured":"Jenkins SJ, Hewitson JP, Jenkins GR, Mountford AP. Modulation of the host\u02bcs immune response by schistosome larvae. Parasite Immunol. 2005;27:385\u201393.","journal-title":"Parasite Immunol."},{"key":"3697_CR54","first-page":"219","volume":"8","author":"EJ Pearce","year":"1987","unstructured":"Pearce EJ, Sher A. Mechanisms of immune evasion in schistosomiasis. Contrib Microbiol Immunol. 1987;8:219\u201332.","journal-title":"Contrib Microbiol Immunol."},{"key":"3697_CR55","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1084\/jem.193.10.1135","volume":"193","author":"V Angeli","year":"2001","unstructured":"Angeli V, Faveeuw C, Roye O, Fontaine J, Teissier E, Capron A, et al. Role of the parasite-derived prostaglandin D2 in the inhibition of epidermal Langerhans cell migration during schistosomiasis infection. J Exp Med. 2001;193:1135\u201347.","journal-title":"J Exp Med."}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3697-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13071-019-3697-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-019-3697-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T17:13:36Z","timestamp":1695230016000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-019-3697-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3697"],"URL":"https:\/\/doi.org\/10.1186\/s13071-019-3697-z","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Animal experiments were reviewed and approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (Permit No: 2016-104) and followed the National Guidelines for Experimental Animal Welfare (MOST, China, 2006).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"457"}}